Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4318074 | 0.97 | ALDH1A1 (0.35) | ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10 | |
| SCHEMBL2418354 | 0.94 | ALDH1A1 (0.38) | ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10 | |
| SCHEMBL4880462 | 0.93 | ALDH1A1 (0.37) | ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10 | |
| SCHEMBL15694681 | 0.93 | ALDH1A1 (0.37) | ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10 | |
| SCHEMBL28573457 | 0.87 | ALDH1A1 (0.33) | ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10 | |
| 1,4-Butanediol SCHEMBL7859266 | 0.85 | TSHR (0.41) | ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10 | |
| SCHEMBL7599321 | 0.85 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL31182045 | 0.85 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL1012045 | 0.85 | SMN1; SMN2 (0.41) | ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10 | |
| SCHEMBL12191375 | 0.82 | SMN1; SMN2 (0.43) | ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12410276-B2 | Method of recycling polyurethane materials | CARPENTER ENGINEERED FOAMS BELGIUM BV (BE) | 2025-09-09 | — | — | US | claimed |
| EP-4010414-B1 | IMPROVED METHOD OF RECYCLING POLYURETHANE MATERIALS | CARPENTER ENG FOAMS BELGIUM BV (BE) | 2025-06-18 | — | — | EP | claimed |
| US-20220325031-A1 | IMPROVED METHOD OF RECYCLING POLYURETHANE MATERIALS | RECTICEL (BE) | 2022-10-13 | — | — | US | claimed |
| EP-4010414-A1 | IMPROVED METHOD OF RECYCLING POLYURETHANE MATERIALS | Recticel (BE) | 2022-06-15 | — | — | EP | claimed |
| US-12410276-B2 | Method of recycling polyurethane materials | CARPENTER ENGINEERED FOAMS BELGIUM BV (BE) | 2025-09-09 | — | — | US | disclosed |
| EP-4010414-B1 | IMPROVED METHOD OF RECYCLING POLYURETHANE MATERIALS | CARPENTER ENG FOAMS BELGIUM BV (BE) | 2025-06-18 | — | — | EP | disclosed |
| CN-114806063-B | Composite material with electric conduction, heat conduction and shape memory properties and preparation method thereof | 江苏大学 | 2024-01-05 | — | — | CN | disclosed |
| US-11718717-B2 | Resin composition, method for producing resin composition, film formation method, and cured product | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20220325031-A1 | IMPROVED METHOD OF RECYCLING POLYURETHANE MATERIALS | RECTICEL (BE) | 2022-10-13 | — | — | US | disclosed |
| EP-4010414-A1 | IMPROVED METHOD OF RECYCLING POLYURETHANE MATERIALS | Recticel (BE) | 2022-06-15 | — | — | EP | disclosed |
| US-20180179338-A1 | RESIN COMPOSITION, METHOD FOR PRODUCING RESIN COMPOSITION, FILM FORMATION METHOD, AND CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-06-28 | — | — | US | disclosed |
| US-20180181002-A1 | METHOD OF PATTERN FORMATION AND METHOD OF PRODUCING POLYSILANE RESIN PRECURSOR | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-06-28 | — | — | US | disclosed |
| EP-1855688-A2 | NITRIC OXIDE ENHANCING DIURETIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2007-11-21 | — | — | EP | disclosed |
| WO-2006091716-A2 | NITRIC OXIDE ENHANCING DIURETIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2006-08-31 | — | — | WO | disclosed |
| US-20060189603-A1 | such as 2H-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-[5-(nitrooxy)pentyl]-, 1,1-dioxide; contains at least one nitric oxide enhancing group; excessive water or electrolyte retention conditions; cardiovascular diseases, and diseases resulting from oxidative or endothelial dysfunctions | NITROMED, INC. (US) | 2006-08-24 | — | — | US | disclosed |
| US-5411810-A | Polyester with low glass transition temperature and specified molecular weight and polyester, phenolic and epoxy resins high glass transition; for computers | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1995-05-02 | — | — | US | disclosed |
| US-4956265-A | POLYUNSATURATED WITH ESTER AND CARBOXY GROUPS; PROTECTIVE COATINGS, GRAPHIC ARTS, PHOTORESTS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-09-11 | — | — | US | disclosed |
| US-4914165-A | PHOTOCROSSLINKABLE POLYEPOXIDE POLYESTERS USING POLY (ETHYLENICALLY-UNSATURATED)ALKANOLS AND DICARBOXYLIC ACIDS; PROTECTIVE COATINGS; GRAPHIC ARTS; WEAR RESISTANCE; ADHESION | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-04-03 | — | — | US | disclosed |
| EP-0329298-A2 | Radiation crosslinkable compositions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-08-23 | — | — | EP | disclosed |
| US-4248975-A | FOAM IS PREDOMINANTLY CLOSED-CELL | WITCO CHEMICAL CORPORATION (US) | 1981-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180181002-A1 | METHOD OF PATTERN FORMATION AND METHOD OF PRODUCING POLYSILANE RESIN PRECURSOR | RTN4, RER1, CROCC | ALDH1A1 2894/4885TSHR 4531/4885SMN1; SMN2 1231/4885 |
| US-11718717-B2 | Resin composition, method for producing resin composition, film formation method, and cured product | SEM1, RER1, SMCHD1 | ALDH1A1 1728/4885TSHR 4195/4885SMN1; SMN2 1531/4885 |
| US-20060189603-A1 | such as 2H-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-[5-(nitrooxy)pentyl]-, 1,1-dioxide; contains at least one nitric oxide enhancing group; excessive water or electrolyte retention conditions; cardiovascular diseases, and diseases resulting from oxidative or endothelial dysfunctions | NOS1, NOS3, REN | ALDH1A1 389/4885TSHR 2788/4885SMN1; SMN2 1736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.